Filter
1256
Text search:
drug
susceptibility
Featured
Recommendations
155
New Publications
301
Language
Document type
No document type
682
Studies & Reports
221
Guidelines
210
Manuals
59
Strategic & Response Plan
37
Fact sheets
20
Training Material
14
Situation Updates
10
Online Courses
2
Infographics
1
Countries / Regions
India
63
Western and Central Europe
43
Ethiopia
32
Eastern Europe
31
Kenya
28
Global
27
South Africa
26
Latin America and the Carribbean
24
Tanzania
21
Zambia
19
Nigeria
18
Nepal
18
Africa
18
Bangladesh
16
Uganda
14
Philippines
14
Malawi
13
Ghana
11
Rwanda
11
Asia
11
Liberia
10
Zimbabwe
10
Namibia
9
South–East Asia Region
9
Cambodia
8
Ukraine
8
Sierra Leone
7
Mozambique
6
Peru
6
Eswatini/ Swaziland
6
Russia
6
Pakistan
5
Botswana
5
Lesotho
5
Myanmar / Burma
5
Cameroon
4
Colombia
4
Western Pacific Region
4
Tajikistan
4
Vietnam
4
Burkina Faso
3
Senegal
3
Germany
3
Syria
3
Sudan
3
Brazil
3
Albania
3
Laos
3
Spain
3
Congo, Democratic Republic of
2
USA
2
Saudi Arabia
2
Iraq
2
Jordan
2
Afghanistan
2
Lebanon
2
Turkey
2
Thailand
2
Indonesia
2
Argentina
2
Ecuador
2
Sri Lanka
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Fiji
2
Bhutan
2
Venezuela
2
Iran
2
Georgia
2
North America
2
Gabon
2
United Kingdom
2
Mali
1
Morocco
1
Haiti
1
Gambia
1
China
1
Ireland
1
Papua New Guinea
1
Benin
1
North Macedonia
1
El Salvador
1
Bolivia
1
Greece
1
Libya
1
East and Southern Africa
1
Armenia
1
Timor Leste/ East Timor
1
Qatar
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
390
Clinical Guidelines
152
Public Health
60
Women & Child Health
26
Key Resources
24
Pharmacy & Technologies
18
Capacity Building
16
Toolboxes
TB
361
AMR
186
HIV
107
NTDs
57
COVID-19
43
Mental Health
37
Malaria
26
Planetary Health
22
Rapid Response
21
Pharmacy
18
Ebola & Marburg
14
Refugee
14
Caregiver
12
Cholera
11
Polio
11
Global Health Education
11
NCDs
11
2.0 Rapid Response
9
Conflict
7
Natural Hazards
7
Specific Hazards
5
Disability
4
Zika
3
Health Financing Toolbox
1
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resis
...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo
...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report
...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i
...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty
...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemi
...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T
...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce
...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment
...
Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated TB response. During this period, the National TB and Leprosy Programme (NTLP) registered tremendous success.
The NTLP is
...
Antimicrobial Resistance Surveillance and Research Network | This document contains detail procedures on sample collection, transport, isolation, identification of fungi for the diagnosis of invasive fungal infections and antifungal susceptibility t
...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are
...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr
...
The global increase of healthcare-associated infections (HAI) presents a growing concern in healthcare worldwide. According to the European Centre for Disease Prevention and Control (ECDC), the annual number of HAI exceeds 2.6million and produces the highest estimated amou
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread
...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patte
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr
...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T
...
